Status:
UNKNOWN
Prospective Genomics Initiative on Multiple Synchronous Lung Cancer (PGI-MSLC)
Lead Sponsor:
RenJi Hospital
Conditions:
Multiple Synchronous Lung Cancers (MSLCs)
Eligibility:
All Genders
18+ years
Brief Summary
This prospective study is to characterize the genomic landscape and genetic heterogeneity of multiple synchronous lung cancer (MSLC) in correlation with comprehensive clinical, histopathological and m...
Detailed Description
* To initiate a prospective registry of MSLC patients with high-quality clinical samples and detailed medical data. * To define the clonal relationship, genomic landscape and potential driver alterati...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Confirmed diagnosis of multiple synchronous lung cancers (MSLCs) without metastatic disease
- Signed informed consent
Exclusion
- Medical or psychiatric condition that would preclude informed consent
- History of known high-risk infections
- With metastatic tumors except lung
Key Trial Info
Start Date :
December 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03795155
Start Date
December 1 2018
End Date
November 30 2023
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China, 200127